Recurrent gestational diabetes: Risk factors, diagnosis, management, and implications

被引:87
作者
Bottalico, Joseph N. [1 ]
机构
[1] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Stratford, NJ 08084 USA
关键词
gestational diabetes; recurrence; diabetes mellitus-type 2; diabetes risk factors; prevention; metabolic syndrome; preconception care;
D O I
10.1053/j.semperi.2007.03.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Gestational diabetes mellitus (GDM) should be regarded as a sentinel event in a woman's life that presents challenges and disease prevention opportunities to all providers of health care for women of reproductive age. Prediabetic risk factors are rising in prevalence and include dietary and lifestyle habits, which when superimposed on genetic predisposition contribute to the rising prevalence of type 2 diabetes and GDIVI. There is growing evidence that treatment of GDM matters, with a continuum of adverse pregnancy outcome risks proportional to degrees of maternal glucose intolerance. GDM in an index pregnancy increases the risk of recurrent GDM in subsequent pregnancies, and recurrence rates of up to 70% have been reported. GDM recurrence rates are influenced by maternal health characteristics and past pregnancy history. The risk of later metabolic syndrome and type 2 diabetes is increased in women with a history of GDM and women should be screened for postpartum glucose intolerance. Opportunities to prevent recurrent GDM and later type 2 diabetes require attention to risk factors and plasma glucose status with identification of impaired fasting glucose or impaired glucose tolerance.
引用
收藏
页码:176 / 184
页数:9
相关论文
共 40 条
[1]   Metabolic syndrome at follow-up in women with and without gestational diabetes mellitus in index pregnancy [J].
Albareda, M ;
Caballero, A ;
Badell, G ;
Rodríguez-Espinosa, J ;
Ordóñez-Llanos, J ;
de Leiva, A ;
Corcoy, R .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (08) :1115-1121
[2]  
American College of Obstetricians and Gynecologists, 2001, ACOG PRACT B, V30
[3]  
American Diabetes Association, 2004, DIABETES CARE, V27, ps5 s10
[4]   Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women [J].
Buchanan, TA ;
Xiang, AH ;
Peters, RK ;
Kjos, SL ;
Marroquin, A ;
Goico, J ;
Ochoa, C ;
Tan, S ;
Berkowitz, K ;
Hodis, HN ;
Azen, SP .
DIABETES, 2002, 51 (09) :2796-2803
[5]   REPRODUCIBILITY OF THE ORAL GLUCOSE-TOLERANCE TEST IN PREGNANT-WOMEN [J].
CATALANO, PM ;
AVALLONE, DA ;
DRAGO, NM ;
AMINI, SB .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 169 (04) :874-881
[6]  
*CDCP, 2005, NATL DIAB
[7]   Effect of treatment of gestational diabetes mellitus on pregnancy outcomes [J].
Crowther, CA ;
Hiller, JE ;
Moss, JR ;
McPhee, AJ ;
Jeffries, WS ;
Robinson, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (24) :2477-2486
[8]  
DANILENKODIXON D, 2000, AM J OBSTET GYNECOL, V182, P80
[9]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[10]   Recurrence of gestational diabetes [J].
Foster-Powell, KA ;
Cheung, NW .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1998, 38 (04) :384-387